TAG Invisible Solid Antiperspirant
Natural health product licensed in Canada
- Licence holder
- Procter & Gamble Inc.
- NPN or DIN-HM
- 80002166
- Status
- Inactive licence
- Licence date
- 28 September 2006
- Revision date
- Not provided
- Form
- Bâtonnet
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Trichlorohexahydrate d'aluminium et de zirconium avec glycine | 17 % |
Non-medicinal ingredients
Perfume, Stearyl Alcohol, Huile de ricin hydrogénée, PPG-14-Butyl Ether, Silica Dimethyl Silyate, Myristyl Myristate, silice, Cyclopentasiloxane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Antiperspirant
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. Do not apply to broken skin. If rash or irritation develops, discontinue.
Source
Official Health Canada record, licence 80002166
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.